Brain interleukin-1β and the intrinsic receptor antagonist control peripheral toll-like receptor 3-mediated suppression of spontaneous activity in rats

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Yamato, Masanori ^a   Tamura, Yasuhisa ^a   Eguchi, Asami ^a   Kume, Satoshi ^a   Miyashige, Yukiharu ^a   Nakano, Masayuki ^a,b   Watanabe, Yasuyoshi ^a,b   Kataoka, Yosky ^a,b  

^a RIKEN   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; POLYINOSINIC POLYCYTIDYLIC ACID; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TOLL LIKE RECEPTOR 3; ALPHA INTERFERON; MESSENGER RNA; N-(2-CYCLOHEXYLOXY-4-NITROPHENYL)METHANESULFONAMIDE; NITROBENZENE DERIVATIVE; SULFONAMIDE;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; BRAIN CORTEX; BRAIN LEVEL; CHRONIC INFLAMMATION; CONTROLLED STUDY; FATIGUE; FEVER; GENE OVEREXPRESSION; MALE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAT; SEROTONINERGIC SYSTEM; SPONTANEOUS ACTIVITY; ANIMAL; ANIMAL BEHAVIOR; BRAIN; DRUG EFFECTS; GENETICS; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; INTERFERON-ALPHA; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MALE; NITROBENZENES; POLY I-C; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SULFONAMIDES; TOLL-LIKE RECEPTOR 3;

EID: 84897995148     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090950     Document Type: Article

References (40)

1. Conn CA, McClellan JL, Maassab HF, Smitka CW, Majde JA, et al. (1995) Cytokines and the acute phase response to influenza virus in mice. Am J Physiol 268: R78-84.
2. Leon LR (2004) Hypothermia in systemic inflammation: role of cytokines. Front Biosci 9: 1877-1888.
3. Traynor TR, Majde JA, Bohnet SG, Krueger JM (2007) Interferon type I receptor-deficient mice have altered disease symptoms in response to influenza virus. Brain Behav Immun 21: 311-322. (Pubitemid 46199114)
4. Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, et al. (2009) The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis 24: 27-53.
5. Magrone T, Marzulli G, Jirillo E (2012) Immunopathogenesis of neurodegenerative diseases: current therapeutic models of neuroprotection with special reference to natural products. Curr Pharm Des 18: 34-42.
6. Matsumoto M, Funami K, Oshiumi H, Seya T (2004) Toll-like receptor 3: a link between toll-like receptor, interferon and viruses. Microbiol Immunol 48: 147-154. (Pubitemid 38405076)
7. Katafuchi T, Kondo T, Yasaka T, Kubo K, Take S, et al. (2003) Prolonged effects of polyriboinosinic:polyribocytidylic acid on spontaneous running wheel activity and brain interferon-alpha mRNA in rats: a model for immunologically induced fatigue. Neuroscience 120: 837-845. (Pubitemid 36928080)
8. Morikawa O, Sakai N, Obara H, Saito N (1998) Effects of interferon-alpha, interferon-gamma and cAMP on the transcriptional regulation of the serotonin transporter. Eur J Pharmacol 349: 317-324. (Pubitemid 28277103)
9. Katafuchi T, Kondo T, Take S, Yoshimura M (2005) Enhanced expression of brain interferon-alpha and serotonin transporter in immunologically induced fatigue in rats. Eur J Neurosci 22: 2817-2826. (Pubitemid 41811279)
10. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9: 46-56. (Pubitemid 350295688)
11. McGeer PL, McGeer EG (2001) Inflammation, autotoxicity and Alzheimer disease. Neurobiol Aging 22: 799-809. (Pubitemid 34066546)
12. Shaftel SS, Griffin WS, O'Banion MK (2008) The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. J Neuroinflammation 5: 7.
13. Allan SM, Tyrrell PJ, Rothwell NJ (2005) Interleukin-1 and neuronal injury. Nat Rev Immunol 5: 629-640. (Pubitemid 41113194)
14. Hu X, Nesic-Taylor O, Qiu J, Rea HC, Fabian R, et al. (2005) Activation of nuclear factor-kappaB signaling pathway by interleukin-1 after hypoxia/ischemia in neonatal rat hippocampus and cortex. J Neurochem 93: 26-37. (Pubitemid 40463512)
15. Loddick SA, Wong ML, Bongiorno PB, Gold PW, Licinio J, et al. (1997) Endogenous interleukin-1 receptor antagonist is neuroprotective. Biochem Biophys Res Commun 234: 211-215. (Pubitemid 27267562)
16. Pinteaux E, Rothwell NJ, Boutin H (2006) Neuroprotective actions of endogenous interleukin-1 receptor antagonist (IL-1ra) are mediated by glia. Glia 53: 551-556.
17. Abe C, Tashiro T, Tanaka K, Ogihara R, Morita H (2009) A novel type of implantable and programmable infusion pump for small laboratory animals. J Pharmacol Toxicol Methods 59: 7-12.
18. Paxinos G, Watson C (1998) The Rat Brain in Stereotaxic Coordinates. San Diego: Academic Press.
19. Cao C, Matsumura K, Shirakawa N, Maeda M, Jikihara I, et al. (2001) Pyrogenic cytokines injected into the rat cerebral ventricle induce cyclooxygenase-2 in brain endothelial cells and also upregulate their receptors. Eur J Neurosci 13: 1781-1790. (Pubitemid 32488067)
20. Koo JW, Duman RS (2008) IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci U S A 105: 751-756.
21. Dinarello CA, Thompson RC (1991) Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today 12: 404-410.
22. Burak KW, Le T, Swain MG (2002) Increased sensitivity to the locomotor-activating effects of corticotropin-releasing hormone in cholestatic rats. Gastroenterology 122: 681-688. (Pubitemid 34173820)
23. Fortier ME, Kent S, Ashdown H, Poole S, Boksa P, et al. (2004) The viral mimic, polyinosinic:polycytidylic acid, induces fever in rats via an interleukin-1-dependent mechanism. Am J Physiol Regul Integr Comp Physiol 287: R759-766. (Pubitemid 39280460)
24. Porkka-Heiskanen T, Strecker RE, Thakkar M, Bjorkum AA, Greene RW, et al. (1997) Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness. Science 276: 1265-1268.
25. Masino SA, Dunwiddie TV (1999) Temperature-dependent modulation of excitatory transmission in hippocampal slices is mediated by extracellular adenosine. J Neurosci 19: 1932-1939. (Pubitemid 29133371)
26. Flagmeyer I, Haas HL, Stevens DR (1997) Adenosine A1 receptor-mediated depression of corticostriatal and thalamostriatal glutamatergic synaptic potentials in vitro. Brain Research 778: 178-185. (Pubitemid 28039901)
27. Craig AD (2009) Emotional moments across time: a possible neural basis for time perception in the anterior insula. Philos Trans R Soc Lond B Biol Sci 364: 1933-1942.
28. Rosenkranz MA, Busse WW, Johnstone T, Swenson CA, Crisafi GM, et al. (2005) Neural circuitry underlying the interaction between emotion and asthma symptom exacerbation. Proc Natl Acad Sci U S A 102: 13319-13324. (Pubitemid 41325021)
29. Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, et al. (2009) Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry 66: 407-414.
30. Hannestad J, Subramanyam K, Dellagioia N, Planeta-Wilson B, Weinzimmer D, et al. (2012) Glucose metabolism in the insula and cingulate is affected by systemic inflammation in humans. J Nucl Med 53: 601-607.
31. Di Santo E, Benigni F, Agnello D, Sipe JD, Ghezzi P (1999) Peripheral effects of centrally administered interleukin-1beta in mice in relation to its clearance from the brain into the blood and tissue distribution. Neuroimmunomodulation 6: 300-304. (Pubitemid 29305608)
32. Konsman JP, Veeneman J, Combe C, Poole S, Luheshi GN, et al. (2008) Central nervous action of interleukin-1 mediates activation of limbic structures and behavioural depression in response to peripheral administration of bacterial lipopolysaccharide. Eur J Neurosci 28: 2499-2510.
33. Chen G, Reichlin S (1999) Mechanisms by which blood levels of interleukin-6 (IL-6) are elevated after intracerebroventricular injection of IL-1beta in the rat: neural versus humoral control. Endocrinology 140: 5549-5555. (Pubitemid 30645342)
34. Magee WE, Griffith MJ (1972) The liver as a site for interferon production in response to poly I:poly C. Life Sci II 11: 1081-1086.
35. Manetti R, Annunziato F, Tomasevic L, Gianno V, Parronchi P, et al. (1995) Polyinosinic acid: polycytidylic acid promotes T helper type 1-specific immune responses by stimulating macrophage production of interferon-alpha and interleukin-12. Eur J Immunol 25: 2656-2660.
36. Loftis JM, Huckans M, Ruimy S, Hinrichs DJ, Hauser P (2008) Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1beta and tumor necrosis factor-alpha. Neurosci Lett 430: 264-268.
37. Kaneko N, Kudo K, Mabuchi T, Takemoto K, Fujimaki K, et al. (2006) Suppression of cell proliferation by interferon-alpha through interleukin-1 production in adult rat dentate gyrus. Neuropsychopharmacology 31: 2619-2626. (Pubitemid 44764159)
38. Thambisetty M, Simmons A, Velayudhan L, Hye A, Campbell J, et al. (2010) Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psychiatry 67: 739-748.
39. Song C, Wang H (2011) Cytokines mediated inflammation and decreased neurogenesis in animal models of depression. Prog Neuropsychopharmacol Biol Psychiatry 35: 760-768.
40. Koo JW, Duman RS (2009) Evidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression. Curr Opin Investig Drugs 10: 664-671. Technology Technology Technology